Key result
SleepCVD-Net AI achieves ~98% accuracy for automatic CVD screening using nocturnal physiological signals.
Why the study?
Does a multimodal AI algorithm (SleepCVD-Net) using nocturnal physiological signals accurately screen for cardiovascular diseases?
Observational (n=194)
Yes
Does a multimodal AI algorithm (SleepCVD-Net) using nocturnal physiological signals accurately screen for cardiovascular diseases?
A multimodal AI algorithm using nocturnal ECG, airflow, and SpO2 signals can accurately screen for cardiovascular diseases including stroke, angina, and heart failure during sleep.
Answers are grounded in this paper and cite their sources.
Supports nocturnal AI screening feasibility for CVDs; leaves open prospective validation before clinical adoption.
This study proposes a multimodal AI algorithm called the SleepCVD-Net to automatically screen CVDs based on nocturnal physiological recordings. We designed and implemented a multimodal AI algorithm, SleepCVD-Net, which utilizes three-mode deep neural networks to process input signals—single-lead electrocardiography (ECG), Airflow, and oxygen saturation (SpO 2 ). Nocturnal physiological recordings were extracted from 194 subjects (80 controls and 114 subjects with CVD) in the Sleep Heart Health Study database. The proposed SleepCVD-Net model demonstrated good performance, achieving a mean accuracy of 97.55% on the test set. The F1-scores were 97.97%, 96.35%, 97.79%, and 97.49% for the control, stroke, angina, and congestive heart failure groups, respectively. The results indicate the potential for the automatic screening of CVDs based on nocturnal physiological signals. Furthermore, the SleepCVD-Net can serve as a valuable tool for monitoring cardiac activity during sleep in inpatient, outpatient, and home healthcare settings.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) conducted an observational in Cardiovascular diseases (n=194). SleepCVD-Net (multimodal AI algorithm) vs. Healthy controls was evaluated on Mean accuracy of cardiovascular disease screening on the test set. The SleepCVD-Net multimodal AI algorithm achieved a mean accuracy of 97.55% for the automatic screening of cardiovascular diseases based on nocturnal physiological signals.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: